Recommended

Resilient supply: safeguarding Europe’s generics
Sanofi’s ‘factory of the future’ vision
AI Act: data governance and compliance implications
mRNA vaccine research cut by RFK Jr
EU Biotech Act public consultation opens
FDA PreCheck programme encourages new manufacturing sites
President Trump targets US pharma supply chain resilience
CDMO Ofichem acquires Uppsala site from Meribel
WEBINAR | Mastering Impurity Profiling: USP’s Evolving Standards and Strategies | 15 OCT
webinar

A 360 overview of data integrity in life sciences

Supported by:

21 April 2020

Watch now
12
SHARES

Supported by:

21 April 2020

Watch now

OSIsoft Webinar

Trustworthiness in data is critical for operations within the pharmaceutical and life sciences industries, whether it is for compliance, operational excellence, reporting or development. Data integrity enables accessibility and trustworthiness in all types of data generated in several areas such as development, by CMOs or in production. As more people, systems and tools consume data, it becomes increasingly valuable because it can be translated into action to improve quality and performance while reducing costs and time to market. However, with additional systems and users comes a risk that, if not managed correctly, can compromise the integrity of data. OSIsoft recently researched the maturity of data integrity within life sciences companies in Europe, Northern America and China. The research shows that data integrity is important and prioritised but still some companies might struggle with this initiative.

Register

Register to watch this on-demand webinar

    Unless making a secure payment with your credit or debit card via a third-party payment processor, this form is not designed to collect confidential or sensitive personal information (e.g., financial information, social security numbers).

    *Required field

    Your details


    *


    *


    *


    *


    *



    *

    Other information

    Email preferences

    If you’re not already opted-in to receive our emails, please select which types of communication you would like to receive:


    Confirm that you're human

    By clicking register, you consent to European Pharmaceutical Review contacting you about this and future webinars, and that you agree to our terms and conditions and privacy policy. Your information will be processed in accordance with GDPR and you can unsubscribe at any time.

    Learning outcomes

    Learning outcomes of this webinar:

    • Hear the latest findings from OSIsoft’s research
    • Learn the most common pitfalls and challenges life sciences companies are facing when improving their data integrity
    • Understand how to avoid these challenges
    • See data integrity success stories.

    Speaker

    Speaker:

    Petter Moree, Life Sciences Industry Principal, OSIsoft

     

    ACCESS your FREE COPY

     


    This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.

    Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.

    What you’ll discover:

    • Key trends shaping the pharmaceutical formulation sector
    • Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
    • Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
    • And more!

    Don’t miss your chance to access this exclusive report ! Access now – it’s free

    Petter Moree

    Petter Moree is Global Industry Principal at OSIsoft, specialising in the life sciences and pharmaceutical industries. He has an MSc. in technical chemistry with a specialisation towards chemometrics and data science from Umea University in Sweden and has over 20 years’ experience helping leading global enterprises obtain optimal value using best practices in data science.

    Share via
    Share via